行情

TRIB

TRIB

Trinity Biotech
NASDAQ

实时行情|Nasdaq Last Sale

0.9900
+0.0705
+7.67%
交易中 14:21 11/22 EST
开盘
0.8900
昨收
0.9195
最高
0.9927
最低
0.8900
成交量
1.91万
成交额
--
52周最高
3.360
52周最低
0.6300
市值
2,380.01万
市盈率(TTM)
-0.6871
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TRIB 新闻

  • 机构观点:未来五到十年,金价的表现将明显好于美股
  • 新浪财经.7小时前
  • 可预知的震荡正在袭来 这个3万亿美元的市场将受牵连
  • 新浪财经综合.7小时前
  • 比特币24小时累计跌超10% 到底发生了什么?
  • 新浪财经综合.7小时前
  • 拉加德:全球经济面临两大挑战 需关注世界经济新秩序
  • 新浪财经综合.7小时前

更多

所属板块

医疗设备、用品及经销
+0.32%
医疗设备和用品
+0.11%

热门股票

名称
价格
涨跌幅

TRIB 简况

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
展开

Webull提供Trinity Biotech plc (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。